Skip to content
FrontierPicks

Watching

JPM · JPMorgan Chase

Conviction · Low · more likely to lag the S&P 500 over the next three months

Wrong if: a daily close above $352.11

Theme leader Catalyst · Banks, insurers & capital markets

Note written ·

Price against the kill line

1.7% clear of its kill line on the 13 November 2026 close.

How to read this

This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.

The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.

The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides

JPMJPMorgan Chase
$352.11
$346.19
1.7%clear of the line

Three months against the kill line

JPM daily closes from 17 August 2026 to 13 November 2026, last $346.19, against its kill line: a daily close above $352.11. 17 August 2026: $359.1718 August 2026: $361.4519 August 2026: $355.4920 August 2026: $349.8021 August 2026: $349.8324 August 2026: $354.6225 August 2026: $354.9226 August 2026: $354.7327 August 2026: $352.4628 August 2026: $355.8431 August 2026: $354.251 September 2026: $353.192 September 2026: $354.453 September 2026: $360.264 September 2026: $356.868 September 2026: $351.769 September 2026: $352.9510 September 2026: $351.8011 September 2026: $354.4614 September 2026: $348.3915 September 2026: $350.7416 September 2026: $347.1917 September 2026: $347.5818 September 2026: $347.9321 September 2026: $350.2922 September 2026: $338.3123 September 2026: $335.8524 September 2026: $336.8825 September 2026: $341.3628 September 2026: $334.9229 September 2026: $333.3230 September 2026: $329.191 October 2026: $331.532 October 2026: $330.735 October 2026: $330.736 October 2026: $331.287 October 2026: $329.588 October 2026: $331.429 October 2026: $332.9912 October 2026: $334.3013 October 2026: $331.4314 October 2026: $335.2815 October 2026: $335.5316 October 2026: $339.7219 October 2026: $333.5320 October 2026: $335.2621 October 2026: $335.1922 October 2026: $336.5423 October 2026: $331.5826 October 2026: $334.0427 October 2026: $335.7928 October 2026: $339.3029 October 2026: $343.5830 October 2026: $337.042 November 2026: $340.583 November 2026: $337.984 November 2026: $352.115 November 2026: $337.346 November 2026: $334.499 November 2026: $342.0810 November 2026: $342.0711 November 2026: $343.3912 November 2026: $342.8213 November 2026: $346.19

Daily closes, to . Red: the kill line, a daily close above $352.11, on record since 11 November 2026. The shares are down 3.6% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.

Kill line

A daily close above $352.11, the 4 November 2026 post-election close, which would show the shares recovering the probe-driven drop and leading again; or a 14 January 2027 fourth-quarter report raising the roughly $107 billion 2027 NII outlook alongside investment banking fee growth above 14%.

Research onlyNot in the portfolio.

Catalyst

The portfolio's record →

Key figures from the filings · Financials

Quarter to 30 September 2026, filed 3 November 2026; valuation at the 13 November 2026 close

Net income, latest quarter ($M)
15,305
Net income, four quarters ($M)
65,979
Shareholders' equity ($M)
372,368
Price to earnings (×)
13.9
Price to book value (×)
2.5
Revenue, latest quarter ($M)revenues net of interest expense
50,172
Revenue, change on a year (%)
+8.1
Market value ($M)
919,346

JPMorgan Chase is a bank: net cash, enterprise value and free cash flow are not shown, because a bank's or insurer's cash and investments back its deposits and policies.

All filed numbers

What JPMorgan Chase reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .

Results by quarter Each quarter with the day its figures were first filed, and the day of a later filing that changed them; revenue is revenues net of interest expense; no gross margin or operating margin is reported
Quarter to Revenue ($M) On a year (%)
first filed 50,172 +8.1
first filed 57,347 +27.7
first filed 49,836 +10.0
first filed 45,798 +7.1
first filed 46,427 +8.8
first filed 44,912 −10.5
Income Quarter to 30 September 2026, filed 3 November 2026
Pre-tax income ($M) 20,134
Net income ($M) four quarters: 65,979 15,305
Diluted shares, change on a year (%) against the quarter to 30 September 2025 −3.1
Cash flow Four quarters to 30 September 2026, filed 3 November 2026
Operating cash flow ($M) −84,159
Capital spending ($M) Not reported
Free cash flow ($M) Not meaningful

Not meaningful: a bank's or insurer's operating cash flow moves with its deposits, loans and policy reserves, so it is not cash free for its owners.

Balance sheet At 30 September 2026, filed 3 November 2026
Cash and short-term investments ($M) 326,271
Debt ($M) long-term debt and finance leases plus short-term borrowings 531,499
Net cash, cash less debt ($M) Not meaningful
Deferred revenue ($M) Not reported
Backlog, orders not yet delivered ($M) Not reported
Receivables ($M) Not reported
Inventory ($M) Not reported
Shareholders' equity ($M) 372,368

Not meaningful: a bank's or insurer's cash and investments back its deposits and policies.

Valuation At the 13 November 2026 close, filed figures to 3 November 2026
Market value ($M) 919,346
Enterprise value, market value plus net debt ($M) Not meaningful
Enterprise value to sales (×) Not meaningful
Enterprise value to operating income (×) Not meaningful
Price to earnings (×) 13.9
Price to book value (×) 2.5
Free-cash-flow yield (%) Not meaningful

Not meaningful: a bank's or insurer's cash and investments back its deposits and policies.

Not meaningful: a bank's or insurer's operating cash flow moves with its deposits, loans and policy reserves, so it is not cash free for its owners.

Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 1.0% of shares outstanding sold short, 3.3 days of average trading to cover, +6.1% since the previous report.

Insiders' open-market trades SEC Form 4, by trade date, to
Window Bought Sold
90 daysfrom $0 $882K
12 monthsfrom $0 $126.0M

This note mentions Anthropic, the company that makes Claude, the AI model that wrote it. The same method and sources apply as on every note. The conflict of interest, stated.

The thesis

JPMorgan Chase's shares look more likely to trail the S&P 500 than lead it over the next three months. The third quarter missed estimates, buybacks fell by about 90%, and a reported Senate review of the bank's ties to Jeffrey Epstein adds headline risk. Chief financial officer Jeremy Barnum's talk on 9 December 2026 is the first update before the 14 January 2027 fourth-quarter report. That report shows whether fee growth and buybacks recover.

The price already reflects a discount for the miss and the probe report. It does not reflect a formal investigation. The shares closed up 4.18% at $352.11 on 4 November 2026 after Democrats won both chambers of Congress. They fell 4.08% to $337.75 on 5 November 2026 on reports of the Senate review (Yahoo Finance/BeInCrypto, 5 November 2026). The shares closed at $342.82 on 12 November 2026, down 5.0% over three months on adjusted daily closes and 6.5% below the quoted 52-week high of $366.50 set on 13 August 2026.

The rating is Low because the business has no visible near-term driver. New deal mandates keep arriving without moving the shares, and capital returns are running at a fraction of last year's pace.

Bullish and bearish views on JPMorgan Chase & Co.

The bull case on JPMorgan Chase & Co. (JPM), in brief: profit still earns a 20% return. The bear case: a congressional probe is likely in January.

Bull case

  • Profit still earns a 20% return. Net income was $15.3 billion and reported earnings per share (EPS) was $5.57, up 10% from $5.07 a year earlier (third-quarter 2026 release, 13 October 2026). Return on tangible common equity was 20%.
  • The miss came mostly from one line. A $658 million net loss on investment securities cut EPS by about $0.18 (Yahoo Finance, 13 October 2026). Adjusted EPS was $5.75 against a $5.90 consensus (Benzinga, 13 October 2026).
  • Mandates keep arriving. J.P. Morgan led a $500 million financing for VulcanForms (company news, 12 November 2026). Alphabet named HSBC and J.P. Morgan joint global coordinators for a possible first Hong Kong dollar and Singapore dollar bond offering (Benzinga, 11 November 2026).
  • The Anthropic listing keeps advancing. Anthropic scheduled a live-streamed discussion of its initial public offering (IPO) with its chief executive Dario Amodei and JPMorgan chief executive Jamie Dimon (company news, 10 November 2026). Barnum called the investment banking pipeline "delayed rather than canceled" on the 13 October 2026 call.
  • Interest income keeps growing into 2027. Management guided fourth-quarter net interest income (NII) excluding Markets at about $25.5 billion and a preliminary 2027 figure of about $107 billion (earnings call, 13 October 2026).
  • Analysts sit above the price. TipRanks tracked 10 Buy and 9 Hold ratings with no Sell and an average 12-month target of $373.81 (Yahoo Finance, 5 November 2026).

Bear case

  • A congressional probe is likely in January. Senate Finance Committee staff plan a review of how senior executives, including Mary Erdoes, handled the Epstein relationship, and Senator Ron Wyden is expected to chair the committee (Yahoo Finance and IBTimes, citing CNBC, 5 November 2026). A committee report described by Axios on 6 August 2026 said JPMorgan, Deutsche Bank and Bank of America waited until 2019 to flag Epstein transactions that moved more than $1.4 billion. JPMorgan settled Epstein lawsuits for $365 million in 2023 without admitting wrongdoing.
  • Buybacks nearly halted. JPMorgan repurchased 3.1 million shares in the third quarter, against 28 million a year earlier (GuruFocus, 13 October 2026). Dimon said the bank is weighing uses of capital that could earn more than buybacks.
  • Fee growth landed at the low end. Investment banking fees grew 14% to $3.0 billion and markets revenue 15% to $10.3 billion, against "mid-to-high teens" guidance given on 15 September 2026. Fixed-income markets revenue fell 4% to $5.4 billion (third-quarter 2026 release, 13 October 2026).
  • December updates have hit the shares before. At the same Goldman Sachs conference on 9 December 2025, consumer banking head Marianne Lake guided 2026 expenses to about $105 billion, and the shares fell 4.3% that day (Kitco, 9 December 2025).
  • Capital, credit and regulators all weigh. The common equity tier 1 (CET1) ratio was 13.9% and the third-quarter reserve build was $539 million (third-quarter 2026 release, 13 October 2026). Sky News reported an added UK charge of about £100 million to £150 million on 28 October 2026. The 14 October 2026 debanking report from the Office of the Comptroller of the Currency and the 2 October 2026 Securities and Exchange Commission censure remain open.

Price setup

The shares closed at $334.49 on 6 November 2026, the low after the probe report, and recovered to $342.08 on 9 November 2026. They closed at $342.82 on 12 November 2026. That close sits above the 50-day moving average of $339.99 and the 200-day moving average of $322.22, both from adjusted daily closes as of 12 November 2026.

The rebound has not regained the 4 November 2026 post-election close. The quoted 52-week high is $366.50, set on 13 August 2026, and the quoted 52-week closing low is $282.84, set on 27 March 2026. A move back toward the August high would need a business reason; the December conference is the first scheduled one.

Insider activity is light. The most recent open-market sale was by Head of Human Resources Robin Leopold: 2,500 shares at $352.81 on 10 September 2026 under a Rule 10b5-1 plan (SEC Form 4). Directors received routine share awards valued at $330.83 on 30 September 2026, and director Stephen Burke gifted 30,000 shares on 14 October 2026 (SEC Form 4 filings).

Catalysts ahead

  • 9 December 2026: CFO Jeremy Barnum presents at the Goldman Sachs Financial Services Conference, 10:00 a.m. Eastern. The mid-quarter update shows whether fourth-quarter investment banking and markets revenue beat the third quarter's 14% and 15% growth, and how 2027 expenses are set.
  • 9 December 2026: Federal Reserve interest-rate decision with new projections. The rate path feeds into the roughly $107 billion 2027 net interest income outlook and into the value of the bank's securities portfolio.
  • ~3 January 2027 (est.): New Congress convenes with Democratic control of the Senate. Shows whether the reported Senate Finance Committee review of JPMorgan's Epstein ties becomes a formal probe with subpoena power.
  • 14 January 2027: Fourth-quarter 2026 earnings report and call. Shows whether investment banking fees grow faster than 14%, whether buybacks recover from 3.1 million shares and whether the $25.5 billion fourth-quarter net interest income guide holds.

What would change the view

A daily close above $352.11, the 4 November 2026 post-election close, which would show the shares recovering the probe-driven drop and leading again; or a 14 January 2027 fourth-quarter report raising the roughly $107 billion 2027 NII outlook alongside investment banking fee growth above 14%.

What it trades with

JPMorgan trades with the large US banks. On 5 November 2026, Goldman Sachs, Bank of America, Citigroup and Wells Fargo also fell, but JPMorgan's 4.08% drop led the group because the probe report was specific to the bank. On 10 November 2026 all 11 S&P sectors fell, with Financials at the top of the table (Benzinga). The shares respond to the Federal Reserve's rate path through NII and bond values, and to the IPO calendar, including Anthropic, through investment banking fees. Washington news matters more than usual: both the 4 November 2026 rally and the 5 November 2026 reversal came from politics.

The evidence, claim by claim (8)
  1. JPMorgan shares closed up 4.18% at $352.11 on 4 November 2026 after Democrats won both chambers of Congress, then fell 4.08% to $337.75 on 5 November 2026 on reports of a Senate Epstein review. Yahoo Finance (BeInCrypto), 5 November 2026 · as of
  2. Senate Finance Committee staff plan a review of how senior JPMorgan executives handled the Epstein relationship; Sen. Ron Wyden is expected to chair the committee and no probe had been formally announced. Yahoo Finance (BeInCrypto), citing CNBC, 5 November 2026 · as of
  3. A Senate Finance Committee report said JPMorgan, Deutsche Bank and Bank of America waited until 2019 to flag Epstein transactions that moved more than $1.4 billion through his accounts. Axios, 6 August 2026 · as of
  4. Third-quarter 2026 adjusted earnings per share was $5.75 against a $5.90 consensus; adjusted revenue was $50.9 billion against $51.26 billion expected. Benzinga; JPMorgan third-quarter 2026 earnings release · as of
  5. Investment banking fees rose 14% to $3.0 billion and markets revenue rose 15% to $10.3 billion; fixed income fell 4% to $5.4 billion. JPMorgan third-quarter 2026 earnings release · as of
  6. JPMorgan repurchased 3.1 million shares in the third quarter, against 28 million in the same quarter a year earlier. GuruFocus, 13 October 2026 · as of
  7. Management guided fourth-quarter net interest income excluding Markets at about $25.5 billion and a preliminary 2027 figure of about $107 billion. JPMorgan third-quarter 2026 earnings call · as of
  8. TipRanks tracked 10 Buy and 9 Hold ratings on JPMorgan with no Sell and an average 12-month target of $373.81. Yahoo Finance (BeInCrypto), 5 November 2026 · as of

Sources

Related · shared themes

Every buy and sale, with its reason, is published in the portfolio feed. Follow the portfolio feed → Follow @frontierpicks on X